What are the possible causes of recurrent epigastric pain requiring hospitalization in a patient with normal inflammatory markers, normal liver function tests, and normal pancreatic enzymes (amylase and lipase)?

Recurrent Epigastric Pain Without Inflammatory Markers: Diagnostic Approach

In patients with recurrent epigastric pain requiring hospitalization but with normal inflammatory markers, liver function tests, and pancreatic enzymes, the most likely diagnoses are gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), gastritis, functional disorders including cyclic vomiting syndrome, or early gastric malignancy that has not yet caused systemic inflammation.

Primary Differential Diagnoses

The absence of elevated inflammatory markers, normal liver enzymes, and normal amylase/lipase effectively excludes acute pancreatitis, acute hepatobiliary inflammation, and most infectious processes 1. This clinical picture points toward:

Upper Gastrointestinal Mucosal Disease

• GERD/Esophagitis: Affects up to 42% of Americans monthly and commonly presents with epigastric pain without systemic inflammation 1
• Peptic Ulcer Disease: Incidence 0.1-0.3%, can cause severe recurrent pain without elevated inflammatory markers until perforation occurs 1
• Gastritis: Presents with epigastric pain and normal laboratory values in early stages 1
• Gastric Cancer: Early stages present with nonspecific symptoms and normal labs; now the most common cause of gastric outlet obstruction in adults 1

Functional/Neurovisceral Disorders

Cyclic Vomiting Syndrome (CVS) deserves special attention as it can masquerade as recurrent pancreatitis. This condition follows a stereotyped four-phase pattern: prodromal phase, vomiting phase with severe abdominal pain, recovery phase, and complete inter-episodic wellness 2. Critically, CVS can cause transient pancreatic enzyme elevation even when pancreatic disease is absent, leading to misdiagnosis 2.

Critical Diagnostic Pitfalls

Enzyme Elevation Does Not Equal Pancreatitis

Serum amylase and lipase lack specificity for pancreatic disease. Up to 13% of patients with extrapancreatic causes of abdominal pain show elevated amylase, and 12.5% show elevated lipase 3. Maximum values in non-pancreatic conditions can reach 385 U/L for amylase and 3685 U/L for lipase 3. Only elevations greater than 3 times the upper limit of normal are uncommon in extrapancreatic disease 3.

Normal Enzymes Do Not Exclude Pancreatitis

Conversely, acute pancreatitis can present with normal or minimally elevated enzymes, particularly when imaging is delayed 4. When abdominal distension is present with normal enzymes, early CT imaging is mandatory to exclude life-threatening disorders 4.

Recommended Diagnostic Algorithm

Step 1: Upper Endoscopy (First-Line)

Endoscopy with biopsy is the reference standard for diagnosing GERD, esophagitis, PUD, gastritis, and gastric cancer 1. This should be performed first given the high pretest probability of mucosal disease in this clinical scenario.

Step 2: If Endoscopy is Normal or Unavailable

Proceed with imaging based on symptom pattern:

For suspected GERD/esophagitis/PUD/gastritis:

• CT abdomen and pelvis with IV contrast is usually appropriate when symptoms are nonspecific 1
  • Use neutral oral contrast (water or dilute barium) to delineate intraluminal space 1
  • CT can detect distal esophageal wall thickening ≥5 mm (88% specificity for reflux esophagitis) 1
  • Can identify gastric wall thickening, ulcers, or masses 1

For suspected functional disorder:

• Fluoroscopy upper GI series (double-contrast) is beneficial for structural and functional abnormalities 1
  • Sensitivity 88% for esophagitis when combined technique used 1
  • Can reveal gastritis patterns, ulcers, and functional abnormalities 1

Step 3: Pattern Recognition for CVS

Look for these specific features suggesting CVS rather than organic disease 2:

• Stereotyped episodes: Each attack follows identical pattern
• Four-phase cycle: Prodrome → vomiting → severe pain → recovery with complete inter-episodic wellness
• Associated symptoms: Migraine-type features (headache, sinus congestion)
• Family history: Strong migraine history
• Post-episode constipation: Characteristic finding

If this pattern is present, consider migraine prophylaxis (topiramate) rather than pursuing further pancreatic workup 2.

When to Suspect Gastric Malignancy

Gastric cancer must be excluded given its 32% five-year survival rate and tendency to present with nonspecific symptoms 1. Red flags include:

• Progressive symptoms despite treatment
• Weight loss
• Anemia
• Age >50 years
• CT findings: nodular/irregular wall thickening, soft tissue attenuation (not edema), lymphadenopathy 1

Key Management Points

Do not anchor on "recurrent pancreatitis" based solely on enzyme elevation. The diagnostic efficiency of lipase for pancreatitis is only 94%, and amylase only 91% 3. Both enzymes are redundant measures with strong correlation (r=0.87) in both pancreatic and extrapancreatic disease 3.

Initiate empiric PPI therapy while awaiting endoscopy, as GERD and PUD are the most common causes and respond to acid suppression 1.

Avoid repeated hospitalizations without definitive diagnosis. The recurrent nature demands aggressive diagnostic workup with endoscopy and appropriate imaging to establish the correct diagnosis and prevent complications such as perforation (30% mortality in PUD) 1.